These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 26752095)

  • 1. Design and synthesis of calindol derivatives as potent and selective calcium sensing receptor agonists.
    Kiefer L; Beaumard F; Gorojankina T; Faure H; Ruat M; Dodd RH
    Bioorg Med Chem; 2016 Feb; 24(4):554-69. PubMed ID: 26752095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N2-benzyl-N1-(1-(1-naphthyl)ethyl)-3-phenylpropane-1,2-diamines and conformationally restrained indole analogues: development of calindol as a new calcimimetic acting at the calcium sensing receptor.
    Kessler A; Faure H; Petrel C; Ruat M; Dauban P; Dodd RH
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3345-9. PubMed ID: 15149704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular determinants of non-competitive antagonist binding to the mouse GPRC6A receptor.
    Faure H; Gorojankina T; Rice N; Dauban P; Dodd RH; Bräuner-Osborne H; Rognan D; Ruat M
    Cell Calcium; 2009; 46(5-6):323-32. PubMed ID: 19836834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular actions of calcimimetics: role of Ca²(+) -sensing receptors versus Ca²(+) influx through L-type Ca²(+) channels.
    Thakore P; Ho WS
    Br J Pharmacol; 2011 Feb; 162(3):749-62. PubMed ID: 20958288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calindol, a positive allosteric modulator of the human Ca(2+) receptor, activates an extracellular ligand-binding domain-deleted rhodopsin-like seven-transmembrane structure in the absence of Ca(2+).
    Ray K; Tisdale J; Dodd RH; Dauban P; Ruat M; Northup JK
    J Biol Chem; 2005 Nov; 280(44):37013-20. PubMed ID: 16135510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The calcilytics Calhex-231 and NPS 2143 and the calcimimetic Calindol reduce vascular reactivity via inhibition of voltage-gated Ca
    Greenberg HZE; Jahan KS; Shi J; Vanessa Ho WS; Albert AP
    Eur J Pharmacol; 2016 Nov; 791():659-668. PubMed ID: 27725162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of highly efficacious allosteric agonists of the human calcium-sensing receptor.
    Ma JN; Owens M; Gustafsson M; Jensen J; Tabatabaei A; Schmelzer K; Olsson R; Burstein ES
    J Pharmacol Exp Ther; 2011 Apr; 337(1):275-84. PubMed ID: 21239511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combination of lanthanum chloride and the calcimimetic calindol delays the progression of vascular smooth muscle cells calcification.
    Ciceri P; Volpi E; Brenna I; Elli F; Borghi E; Brancaccio D; Cozzolino M
    Biochem Biophys Res Commun; 2012 Feb; 418(4):770-3. PubMed ID: 22310712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive and negative allosteric modulators of the Ca2+-sensing receptor interact within overlapping but not identical binding sites in the transmembrane domain.
    Petrel C; Kessler A; Dauban P; Dodd RH; Rognan D; Ruat M
    J Biol Chem; 2004 Apr; 279(18):18990-7. PubMed ID: 14976203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biased allosteric modulation at the CaS receptor engendered by structurally diverse calcimimetics.
    Cook AE; Mistry SN; Gregory KJ; Furness SG; Sexton PM; Scammells PJ; Conigrave AD; Christopoulos A; Leach K
    Br J Pharmacol; 2015 Jan; 172(1):185-200. PubMed ID: 25220431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcimimetics and hyperparathyroidism.
    Krebs LJ
    Curr Opin Investig Drugs; 2004 Oct; 5(10):1080-5. PubMed ID: 15535429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The calcimimetic calindol prevents high phosphate-induced vascular calcification by upregulating matrix GLA protein.
    Ciceri P; Elli F; Brenna I; Volpi E; Brancaccio D; Cozzolino M
    Nephron Exp Nephrol; 2012; 122(3-4):75-82. PubMed ID: 23548867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allosteric agonists of the calcium receptor (CaR): fluorine and SF5 analogues of cinacalcet.
    Chia PW; Brennan SC; Slawin AM; Riccardi D; O'Hagan D
    Org Biomol Chem; 2012 Oct; 10(39):7922-7. PubMed ID: 22940747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of a novel series of [1-(4-hydroxy-benzyl)-1H-indol-5-yloxy]-acetic acid compounds as potent, selective, thyroid hormone receptor β agonists.
    Burkholder TP; Cunningham BE; Clayton JR; Lander PA; Brown ML; Doti RA; Durst GL; Montrose-Rafizadeh C; King C; Osborne HE; Amos RM; Zink RW; Stramm LE; Burris TP; Cardona G; Konkol DL; Reidy C; Christe ME; Genin MJ
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1377-80. PubMed ID: 25752984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive and negative allosteric modulators promote biased signaling at the calcium-sensing receptor.
    Davey AE; Leach K; Valant C; Conigrave AD; Sexton PM; Christopoulos A
    Endocrinology; 2012 Mar; 153(3):1232-41. PubMed ID: 22210744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcimimetic and calcilytic drugs for treating bone and mineral-related disorders.
    Nemeth EF; Shoback D
    Best Pract Res Clin Endocrinol Metab; 2013 Jun; 27(3):373-84. PubMed ID: 23856266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of extracellular calcium-sensing receptor ligands on the contractility of pregnant human myometrium in vitro.
    Crankshaw DJ; Pistilli MJ; O'Brien YM; Sweeney EM; Dockery P; Holloway AC; Morrison JJ
    Reprod Sci; 2013 Aug; 20(8):882-90. PubMed ID: 23287098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and optimization of substituted 1-(1-phenyl-1H-pyrazol-3-yl)methanamines as potent and efficacious type II calcimimetics.
    Poon SF; St Jean DJ; Harrington PE; Henley C; Davis J; Morony S; Lott FD; Reagan JD; Lu JY; Yang Y; Fotsch C
    J Med Chem; 2009 Nov; 52(21):6535-8. PubMed ID: 19835382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and structure-activity relationship studies of 4,11-diaminonaphtho[2,3-f]indole-5,10-diones.
    Shchekotikhin AE; Glazunova VA; Luzikov YN; Buyanov VN; Susova OY; Shtil AA; Preobrazhenskaya MN
    Bioorg Med Chem; 2006 Aug; 14(15):5241-51. PubMed ID: 16631372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allosteric modulators of the extracellular calcium receptor.
    Nemeth EF
    Drug Discov Today Technol; 2013; 10(2):e277-84. PubMed ID: 24050279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.